APA (7th ed.) Citation

Pillay, S. (2026). De novo clinical endocrine immune-related adverse events during immune checkpoint inhibitor therapy in adults with cancer (2000–2025) – a scoping review. Journal of Endocrinology, Metabolism & Diabetes of South Africa, 1. https://doi.org/10.1080/16089677.2026.2665987

Chicago Style (17th ed.) Citation

Pillay, S. "De Novo Clinical Endocrine Immune-related Adverse Events During Immune Checkpoint Inhibitor Therapy in Adults with Cancer (2000–2025) – a Scoping Review." Journal of Endocrinology, Metabolism & Diabetes of South Africa 2026: 1. https://doi.org/10.1080/16089677.2026.2665987.

MLA (9th ed.) Citation

Pillay, S. "De Novo Clinical Endocrine Immune-related Adverse Events During Immune Checkpoint Inhibitor Therapy in Adults with Cancer (2000–2025) – a Scoping Review." Journal of Endocrinology, Metabolism & Diabetes of South Africa, 2026, p. 1, https://doi.org/10.1080/16089677.2026.2665987.